These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Cyclophosphamide in the therapy of multiple sclerosis]. Salvatores U; Majeron M; Mascetti A Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb; 96(1):163-84. PubMed ID: 4337775 [No Abstract] [Full Text] [Related]
7. [Immunosuppressive treatment in multiple sclerosis]. Vermeulen M; Zegerius L; van Crevel H Ned Tijdschr Geneeskd; 1987 Jan; 131(3):93-6. PubMed ID: 3821989 [No Abstract] [Full Text] [Related]
8. The peculiar difficulties of therapeutic trials for multiple sclerosis. Myers LW; Ellison GW Neurol Clin; 1990 Feb; 8(1):119-41. PubMed ID: 1690838 [TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis: a review of existing therapy and future prospects. Khan OA J Pak Med Assoc; 1996 Jan; 46(1):20-4. PubMed ID: 8830165 [TBL] [Abstract][Full Text] [Related]
10. Immunosuppressant treatment in multiple sclerosis. van den Noort S Clin Neuropharmacol; 1985; 8(1):58-63. PubMed ID: 2983891 [No Abstract] [Full Text] [Related]
11. [Multiple sclerosis--current status of therapy]. Reichel D; Kölmel HW Z Arztl Fortbild (Jena); 1995 May; 89(2):151-8. PubMed ID: 7610682 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in multiple sclerosis, Part 2. Becker CC; Gidal BE; Fleming JO Am J Health Syst Pharm; 1995 Oct; 52(19):2105-20; quiz 2132-4. PubMed ID: 8535945 [TBL] [Abstract][Full Text] [Related]
13. Prospects for the treatment of multiple sclerosis. Hughes RA J R Soc Med; 1991 Feb; 84(2):63-5. PubMed ID: 1847975 [No Abstract] [Full Text] [Related]
14. The treatment of multiple sclerosis. Kott HS Med Clin North Am; 1972 May; 56(3):711-6. PubMed ID: 4338391 [No Abstract] [Full Text] [Related]
15. The use of immunosuppressive agents in the treatment of multiple sclerosis: a critical review. Goodin DS Neurology; 1991 Jul; 41(7):980-5. PubMed ID: 2067661 [No Abstract] [Full Text] [Related]
16. [Review of the therapy of multiple sclerosis]. De Rosa A; Puccini A; De Martino V Recenti Prog Med; 1982 Dec; 73(6):651-68. PubMed ID: 6308734 [No Abstract] [Full Text] [Related]
17. Immunosuppressive drugs in multiple sclerosis: pro and con. Ellison GW; Myers LW Neurology; 1980 Jul; 30(7 Pt 2):28-32. PubMed ID: 6248818 [No Abstract] [Full Text] [Related]
19. [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis]. Cazzato G; Antonello RM; Zorzon M; Torre P; Zivadinov R; Moretti R; Bragadin LM; De Masi R; Nasuelli D Recenti Prog Med; 1999 Oct; 90(10):538-44. PubMed ID: 10592740 [TBL] [Abstract][Full Text] [Related]
20. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis. Hauser SL; Fosburg M; Kevy S; Weiner HL Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]